The effect of semaglutide on liver function in NAFLD patietns with DM
Not Applicable
- Conditions
- AFLD
- Registration Number
- JPRN-UMIN000046309
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Liver cirrhosis Patients deemed inappropriate by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in ALT, MRI-PDFF, MR elastography between 24 weeks oral semaglutide therapy
- Secondary Outcome Measures
Name Time Method